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chondrocyte cultures, either from the normal donors or from the 
OA patients, with I L-1 I~ (10 ng/ml, incubation periods ranging from 
5 min to 16 h), TNF-~ (20 ng/ml, 6 h), TGF-I~ (10 ng/ml, 2, 6 and 
16 h-incubation periods) or IGF-1 (100 ng/ml, 6 h) did not change 
NOS I protein levels relatively to the respective controls. 
Conclusions: The results obtained show that OA chondrocytes 
are deficient in NOS I relatively to normal cells and also indicate 
that this protein is not regulated by any of the anabolic or catabolic 
stimuli n the conditions tested. Our previous results showed that, 
in bovine chondrocytes, NOS I is rapidly degraded in response to 
IL-1 and that NO inhibits IL-1 -induced NF-KB activation and iNOS 
expression, indicating that NO participates in a regulatory mech- 
anism that prevents accidental or inappropriate NF-KB activation. 
The absence of the NOS I protein in human OA chondrocytes, 
reported here, suggests that the regulatory mechanism identified 
in normal bovine chondrocytes does not opperate in human OA 
chondrocytes. Thus, the absence of NOS I may contribute to the 
impaired regulation of NF-KB activation and of the expression of 
its target genes, namely, several inflammation-related genes and 
matrix metalloproteinases that contribute to the development and 
progression of arthritic diseases. 
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Few structure-modifying drugs have been used to date for OA 
treatment, and most commonly used medications are symptom- 
modifying drugs, such as NSAIDs. Although both treatments have 
been shown to be effective for improving pain and disability, their 
effects on cartilage and synovial metabolism remain poorly stud- 
ied. 
Aim of the study: To compare the effect of glucosamine sulfate 
(GS) to that seen for different anti-OA drugs, such as NSAI Ds and 
other nutraceuticals on the activation of several proinflammatory 
and structural mediators in OA chondrocytes and synoviocytes in 
culture. 
Methods: Chondrocytes and synoviocytes were obtained from 
joint specimens of OA patients who underwent otal knee replace- 
ment. Using quiescent cells stimulated with 10 U/ML IL-11~, the ef- 
fects of GS (1 mg/ml), meloxicam (MXC, 10-6M), diclofenac (DCF, 
10-6M), indomethacin (IND, 10-6M), chondroitin sulphate (CS, 
1 mg/ml), diacerhein (DC, 10-5M), and N-acetylcysteine (NAC, 
2 mM) on prostaglandin (PG) E2 production, cyclooxigenase- 
2 (COX-2) expression, nitric oxide (NO) synthesis, metallopro- 
teinase (MMP)-I and MMP-13 presence and nuclear factor kappa 
B (NFKB) activation were studied. 
Results: With IL-11~ stimulation, an increased presence of all of 
these mediators was noted, except for NO synthesis in synovio- 
cytes. After stimulation, PGE2 synthesis was significantly inhib- 
ited by GS (up to 60%) and NSAIDs (100%) in both cell types, 
and also by DC (45%) in chondrocytes and by NAC (65%) in 
synoviocytes. COX-2 synthesis, measured by western-blot tech- 
niques, was also inhibited in both cell types by incubation with 
GS (up to 60%) or NSAIDs (up to 40%), while NAC (50%) also 
diminished COX-2 in synoviocytes. In relation to the increase in 
NO synthesis in chondrocytes evoked by IL-11~, only GS (75%), 
DC (30%) and CS (20%) were able to inhibit it, and no effect was 
noted for NSAIDs or NAC. One of the possible cellular mecha- 
nisms involved in the activation of these proinflammatory events 
has also been studied. NFKB activation was only inhibited by 
GS (60%), DC (75%) and DCF (75%) in chondrocytes, and by 
GS (45%), DC (69%), CS (65%)and DCF (60%) in synoviocytes. 
MMP-1 and -13 activation were inhibited only in chondrocytes 
by GS (65% and 75%, respectively). Between other nutraceuti- 
cals, only CS (60%) diminished MMP-1 activity in chondrocytes. 
However, NSAID presence did not modify or even super-induced 
MMP1 and -13 synthesis in both cell types. 
Conclusion: GS inhibits the synthesis of proinflammatory and 
structural mediators in OA chondrocytes and synoviocytes tim- 
ulated by IL-11~. The presence of other nutraceticals only partially 
controlled some of these mediators. NSAIDs were able to signif- 
icantly inhibit proinflammatory pathways, while structural media- 
tors were unchanged or even activated. Our study supports the 
role of GS as a symptom and structure-modifying drug. 
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Aim of Study: The aim of the present study is to investigate the 
effects of platelet rich plasma (PRP) on proliferation and rediffer- 
entiation of cultivated human chondrocytes. 
Methods: Whole blood and knee joint cartilage were supplied 
from 10 adult donors after informed consent. Chondrocytes were 
isolated by enzyme digestion from cartilage and suspended nu- 
trient mixture medium with 10% fetal bovine serum (FBS). When 
cultured dishes became near confluent, cells were passed only 
one time. Blood was drawn into a bag containing anticoagulant 
and centrifuged twice to obtain PRP. By mixing calcium gluconate 
and thrombin to PRP, platelets released growth factors from their 
granule and PRP gel was obtained. MTT assay was used for 
the quantitative determination of cellular proliferation. We inves- 
tigated the effect of different PRP concentrations on chondro- 
cyte proliferation and also performed a time course experiment 
to establish a growth curve of cells cultivated in control condi- 
tion (30% platelet poor plasma) or in 30% PRP. All MTT assays 
were performed using serum-free medium. Redifferentiation of 
cultivated chondrocyte is associated with increased glycosamino- 
glycans (GAGs) and type II collagen expression. Alcian blue and 
anti-type II collagen antibodies were used for histochemical and 
immunohistochemical examinations to analyze the influence of 
PRP on redifferentiation. 
Results: Cell proliferation of human chondrocytes was sensitive 
to PRP. The increase was dose dependent, and MTT values in- 
creased as the percentage of PRP increased. Thirty percent PRP 
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Fig. 1. MTT assay of human chondrocyte. 
* = P<O05 versus control vatue 
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